These compounding pharmacies have to comply with the United States Pharmacopeia (USP) 797 Reference Standards, which are regulations intended to ensure patient safety with compounded sterile medications
Zafardoust S, Didar H, Ganagard MG, Tavakoli M, Arefi S, Arjmandinaloo S, et al
Internal review documentation and Canadian invoicing are supported as standard
Answer : The major players in the GLP-1 analogues market include Novo Nordisk, Eli Lilly and Company, Sanofi, AstraZeneca, Boehringer Ingelheim, Pfizer, Amgen, Roche, Zealand Pharma, Structure Therapeutics, Viking Therapeutics, Hangzhou Sciwind Biosciences, Fudan University, Eccogene, Medtronic, Merck & Co., AbbVie, Bayer AG, Teva Pharmaceutical Industries Ltd., and Boehringer Ingelheim
This allows 0.1ml for 1mg doses or 0.2ml for 2mg doses, volumes easily measured with insulin syringes